Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2026-01-24 @ 8:46 PM
Study NCT ID:
NCT05920668
Status:
UNKNOWN
Last Update Posted:
2023-06-27
First Post:
2023-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma
Sponsor:
Organization: